Marijuana is now legal in two states, and legal for medical use in 23
states and the District of Columbia. Polls show the majority of
Americans support cannabis legalization, and more and more of the
country is joining the legalization trend. As a counselor working with
people diagnosed with psychosis and mental illness I am often asked
about my opinion and clinical experience — as well as my personal
experience — with medical cannabis.
The issue is not clear-cut either way, but I think it is time for
everyone, especially if you are concerned with the risks of
pharmaceutical drugs, to set aside what we think we may know and take a
serious look at cannabis as an option for people with serious mental
health challenges. Medical use of marijuana has clear potential for
reducing psychiatric drug use, drugs that are notorious for their
devastating adverse effects. The decision to use cannabis is not simple,
and along with the War on Drugs anti-pot propaganda there is also a lot
of pro-marijuana fanaticism to wade through, but this is the reality:
many people can forgo pharmaceutical drugs and use cannabis instead.
I don’t need to reiterate the extensive research on medical use of
cannabis available on the internet, and I have already written about
cannabis and substance use in counseling practice in a previous post on
Mad In America ('The Substance of Substance Use”). But here are some
more thoughts about cannabis specifically.
There is now widespread evidence people are already successfully using cannabis to treat psychiatric conditions.
Cannabis has long been used as medicine and spiritual tool throughout
human history, for for far longer than the brief period of prohibition
when it's been criminalized. Criminalization didn’t come from medical
assessment of cannabis’ usefulness, but was instead a political decision
motivated by racism and suppression of the insurgent youth culture.
Extensive studies showing medical benefits — for cancer, Alzheimers,
multiple sclerosis, hepatitis C, irritable bowel, Parkinsons, pain
management, and other conditions — have driven ballot initiative success
around the country. This has begun to convince even longtime opponents,
with US President Obama formally acknowledging cannabis as no more
dangerous than alcohol, and CNN's chief medical correspondent Dr. Sanjay
Gupta, one of the world’s most influential opinion leaders on medicine,
recently reversing his opposition to medical marijuana. Dr. Gupta even
apologized for his previous anti-legalization stance and “not looking
hard enough" at the issue.
But what about mental health conditions?
Around the country, medical marijuana cards are routinely given to
people suffering anxiety, depression, insomnia, ADHD, trauma, and mental
health issues. The internet is replete with a growing number of
testimonies of successful symptom alleviation through cannabis,
including people diagnosed with psychotic disorders such as bipolar and
schizophrenia, These are not just a few anecdotes, these are thousands
of people giving firsthand accounts of benefitting from cannabis for
mental health conditions.
And with the growing number of dispensaries,
review websites, and legal cannabis consumers, these testimonies are
growing in number.
And at the same time, it is not uncommon for me to receive emails like this:
"Our son was doing so well in school, and then he started smoking
marijuana and went psychotic and went into the hospital, where he was
diagnosed with schizophrenia.”
“Before her delusions began I learned she was experimenting with marijuana…”
So what is going on?
Our culture has been saturated for years with a simplistic
prohibition mentality around marijuana. Media reports demonize cannabis,
with many scientific studies were twisted and manipulated to support a
political agenda. Just one notorious example was the Heath/Tulane study
in 1974. which claimed to show marijuana “kills brain cells.” These
findings, reported by a mainstream research institution with impeccable
scientific credentials, were considered gold standard evidence and
quickly became part of the mainstream attitudes.
“Marijuana kills brain
cells” was paraded by President Reagan in his anti-drug propaganda and
brought out by frightened parents everywhere when they discovered a
joint in their teenager’s bedroom. The study even supported extremist
media campaigns like the “This is your brain on drugs” television
commercial, where a broken egg on a hot griddle became the last word on
marijuana dangers.
The Heath/Tulane study was later exposed as pure scientific fraud:
researchers were able to show brain cell death only by pumping so much
marijuana smoke into the laboratory animals that the animals couldn’t
breathe.
It was asphyxiation from lack of oxygen, not ingesting
marijuana, that caused the brain damage. The poltiicization of science
continues, and Dr. Gupta writes that of current US marijuana studies,
94% are designed to investigate harm, not potential benefits. Despite
countless other studies showing marijuana’s benefits and extremely low
risk profile compared to either tobacco or alcohol - two very legal and
very deadly drugs — we have let prohibition politics, not solid science,
shape and continue to determine US drug policy and leadership
worldwide.
This corruption is even more true in mental health, where substance
use has become synonymous with substance
abuse,
and the mental health system oversees abstinence-based treatments that
are often the criminal punishment for users arrested for possession
alone.
No leading mental health organization has publicly expressed
opposition to the War on Drugs or presented an honest discussion of the
potential value of legalization. Mainstream mental health websites
such as National Alliance for the Mentally Ill and the Schizophrenia
Society of Canada continue to echo this demonization.
Any potentially
valuable caution about the role of cannabis use in psychosis - of which I
will discuss more in a moment - gets lost and discredited in the
general “just say no” message. There is no balanced discussion, not of
how cannabis might help some people forgo the risks of psychiatric drugs
relative to the possible risks to adolescent brain development.
Mainstream opinion makers, driven in part by pharmaceutical and American
Medical Association opposition to legalization, have instead elected to
emphasize the psychosis-marijuana link research and ignore everything
else.
NAMI medical director Dr. Ken Duckworth sums it up on the NAMI
website “The overwhelming consensus from mental health professionals is
that marijuana is not helpful—and potentially dangerous—for people with
mental illness.” He doesn’t point out that this consensus is a result of
politics, not medical science. The rest of the policy document has War
on Drugs propaganda on full display. Dr. Duckworth writes,
“Approximately one-third of people in America with schizophrenia
regularly abuse marijuana.”
Really? Can we see a study citation for that
statement? The answer is no, there is no citation because NAMI made
this claim up, there is no research behind it.
Dr. Duckworth also rings the alarm bell of addiction, counting the
mental health industry’s conflation of use and abuse. He states that “a
significant percentage of individuals who use marijuana will become
physically dependent on the drug.
This means that stopping their
marijuana abuse will cause these people to experience a withdrawal
syndrome.” Dr. Gupta, however, disagrees. Dr. Gupta writes on CNN that
“In 1944, New York Mayor Fiorello LaGuardia commissioned research
to be performed by the New York Academy of Science. Among their
conclusions: they found marijuana did not lead to significant addiction
in the medical sense of the word…” He adds, “The physical symptoms of
marijuana addiction are nothing like those of the other drugs I've
mentioned.”
My bet is with Dr. Gupta on this one. As Dr. Gupta’s reversal
indicates, there is a clear case for legalization of cannabis because
there is an undeniable scientific research base — and common sense base -
for cannabis’ benefits relative to its risks. As a recreational drug
there is just no comparing cannabis risks to other drugs such as alcohol
and tobacco. But in the context of the War on Drugs’ demonization,
proponents of marijuana have reacted with a defensive romanticization,
adding to the confusion. Left in a vacuum by mental health and medical
organizations that should have been providing sound and honest
discussion on the issue, the many mainstream research studies on medical
benefits of cannabis are often touted and available on aggressively
pro-marijuana sites.
You feel that you are pulled to one side of the
other in this political - and economic - tug of war. (The pro-marijuana
sites are after all, now burgeoning with advertising revenue from the
surfacing marijuana industry. The message today is “cannabis is good for
you,” and of course the next message will be “buy some today” and then
“from us.”)
As a society we are thankfully stepping away from both demonization
and romanticization. And this means looking at two important facts about
cannabis:
dosage and
strain.
The cannabis of today isn't the cannabis of yesterday. But the
commonplace claim that "marijuana today is stronger than it was in the
past" is far from the whole picture. Yes there is a lot more strong
marijuana out there, but that also has positive implications for medical
use. There is a an increased complexity and sophistication of how
cannabis is being used, in many different ways by many different people,
that has to be understood.
As far as dosage goes, the importance of understanding this complexity is well illustrated by the experience of New York
Times Pulitzer Prize winning columnist Maureen Dowd. In a high-visibility, and influential, act that formed part of
Times
reporting on growing legalization efforts in Colorado and elsewhere,
Dowd got high on pot in Denver. And promptly had a psychotic episode.
She presumably didn’t go on to be diagnosed bipolar, and did not need to
be hospitalized, but her bad trip, replete with delusions of being dead
and paranoid fears of the police, for some might be considered proof
positive that cannabis is a bad idea for anyone “at risk for psychosis.”
Dowd, however, was in effect writing a denunciation of wine by binge
drinking on tequila. “Alcohol makes you sick and pass out” says more
about
how, how much, and
what we drink, than it does
that
we drink alcohol. Simple enough common sense, but that is exactly what
has been lost with prohibition propaganda. Without adequate
understanding, Dowd apparently downed an entire cannabis infused edible
candy. Edibles are notorious for their potency. Then she did what anyone
following sensible marijuana use knows not to do - she gobbled up even
more of the edible when she didn’t feel any effects after a few minutes.
She doubled the eventual impact of the drug, and delivered a massive
dose to her marijuana-naive self after the slow-onset that is standard
for eating marijuana (smoking effects are much faster; eating means the
cannabis has to be digested before experiencing amplified effects.). It
could be humorous - Dowd was lambasted in the internet for her
irresponsibility - if it wasn’t so emblematic of the impact of
prohibition. Rational discussion by a presumably thoughtful professional
journalist turns into nonsense, fuel for more simplistic demonization.
Dosage, including the delivery method (and now there are tinctures,
vaporizers and other methods beyond smoking or eating), is an important
reality to cannabis consumption. If a drug leads to psychosis at a
higher dose, but doesn’t at a lower dose, is the problem the drug or its
use? If a drug at one dose is useful and at a higher dose is harmful,
does that mean the drug is “useful” or “harmful?” So we begin to see one
explanation for how a drug that many people find useful for psychosis
can be the very drug that causes psychosis for many others.
It becomes
more understandable that my email inbox has emails from people blaming
marijuana for mental illness alongside emails from people who’ve been
helped.
Dowd also didn’t chose her strain with any care, and strains can make
a huge difference in cannabis use. There are hundreds of strains of
crossbred hybrid cannabis, with colorful names like Blue Dream, Girl
Scout Cookies, AC/DC, and Lemon Alien Dawg. This diversity isn't just
fanciful or aesthetic: strains differ by aroma and flavor, Much more
importantly, different strains have
drastically different
psychoactive effects. Alcohol intoxication might feel a bit
different between beer, wine, and spirits, but not by much The different
effects between different cannabis strains are like taking completely
different substances.
There are 483 currently known compounds in marijuana, and at least 84
different psychoactive cannabinoids. THC is just one. This may explain
why some people are using marijuana to alleviate psychosis while others
find it makes psychosis worse. Medical marijuana users routinely share
information about the qualities of different strains - some good for
sleep, some for anxiety, some for depression, etc - to help each user
find out what works for them. Of the many alkaloids, cannabidiol (CBD)
is associated with tranquilizing response, while THC causes more
mind-altering, and is potentially paranoia and anxiety inducing.
Similarly, marijuana users have long known that the sativa varieties are
different than the indica; sativa is associated with a more energetic
high, prone to produce anxiety and paranoid in some people. while indica
is more sedating. There is strong evidence that high CBD cannabis can
alleviate psychosis for the simple reason that is is tranquilizing, in
the same way that anti-psychotics are for many people helpful because
they are tranquilizing. CBD, however, clearly lacks the devastating side
effects of antipsychotic drugs.
(The cannabis industry is still only now emerging from the
underground, and with lack of the regulation and quality control of
other industries users still have to rely on trial and error. It’s not a
guarantee that what the dispensary labeled as Blue Dream isn’t actually
Kali Mist, or there isn’t sativa in that tincture marked indica.
Medical users will be better served by legalization, which will allow
greater testing and reliability of supply, as in the wine industry.
The
best role of regulation in the legalization process is fiercely debated
by growers concerned about issues such as ecological sustainability,
labor conditions, and the specter of Big Tobacco-style profiteering. In
Sonoma County where I live, there is a huge marijuana industry and vast
sums of money moving into the state in anticipation of California
following the trend towards full legalization. The legal wine industry
in the area is very shady, and has a deserved reputation for greedy
disregard for the environmental and local community in its rapid
expansion.
That might be a cautionary tale: the gentle
peace-ecology-love aura of marijuana may, some fear, quickly give way to
the cutthroat realities of just another boom industry and agribusiness
product.)
Word about CBD is getting out. Along with the emails from people
tracing psychosis back to marijuana use, I now routinely encounter
people in my work, lucky to be in a legal state or country or able to
risk acquiring pot through the underground, who are using cannabis to
help with distressing experiences associated with psychosis and mental
illness diagnosis.
Some have switched strains to high CBD and found
different effects, some are using cannabis to help come off psych drugs,
some are using cannabis instead of psych drugs, and some - very
interestingly - have gotten benefits from cannabis and never gotten on
psychiatric medications to begin with. Scientific studies on CBD support
what I am seeing: a University of Cologne study from Germany, in a four
week trial, found CBD
as effective as an anti-psychotic in
calming psychotic symptoms. A co-author of the study wrote “Not only was
[CBD] as effective as standard antipsychotics, but it was also
essentially free of the typical side effects seen with antipsychotic
drugs.”
A glance through research results on CBD from studies around the
world shows evidence to support what we know already: CBD marijuana can
help mental health conditions. These users are often careful in dosage,
some even using just a few drops or “homeopathic” doses to get the
desired effects.
(Other research is also intriguing. Numerous studies show anxiety
alleviation, and, consistent with studies on Alzheimers and Parkinsons,
one University of Montreal study published in Psychiatry Research even
showed cannabis users diagnosed with schizophrenia to have better memory
and prefrontal lobe functioning than those not using cannabis.
Could
cannabis be not only a substitute for psychiatric medications, but a
treatment for the harm they caused? And other studies that are more
troubling, such as those showing memory impairment and youth development
harm, are essential to come to terms with in any benefit/risk
assessment, but what do dosage and strain have to do with the results
these studies found?)
So the
kind of cannabis used, as well as the
dosage,
may explain part of the puzzle of different reports around cannabis and
psychosis.
This is in addition to a general principle with all
psychoactive substances, a principle that applies to cannabis as well:
Response to cannabis use is widely diverse and individual. The
medical marijuana dispensary community is thoroughly familiar with the
fact that as a "medicine" cannabis does not provide uniform "treatment."
Instead, just as each individual experiences “illness” differently,
each individual has their own response, and what is right for one person
might not be right for another - including the need to forgo cannabis
altogether.
Some people find the “high” contributes positively their
medical condition and life circumstnaces, others seek out strains that
have helpful effects without the high. Dispensary staff I've met are
skilled at helping individuals navigate different strains and dosages
for individual needs.
Substance abuse is a serious and devastating problem. Some people
find that abstinence is the best strategy, such as following an AA 12
step program. Taking any drug - alcohol, tobacco, or cannabis --
involves risks.
Cannabis needs to be subjected to the same caution, but
overall cannabis is undoubtedly much safer on the body than alcohol or
tobacco (zero marijuana caused deaths compared to many millions of
alcohol and tobacco deaths) and much safer than
any psychiatric
medication. The growing legalization and medicalization of cannabis will
no doubt be used by some to rationalize their addiction or avoid facing
the fact that the drug is not helping them - but this is true of any
substance, including alcohol and psychiatric meds.
Once we step outside
the demonization/romanticization polarity of the War On Drugs mentality
we can engage this complicated reality more clearly.
Saying cannabis might be helpful for some people is not to deny it might make others worse.
What about me personally? I found years ago that marijuana only
worsens my own anxiety and further disconnects me from reality. I was
smoking around the time I was first hospitalized, and though I quit
marijuana I still had another psychotic break many years later when I
wasn’t using and hadn’t used marijuana for 8 years.
I do believe that
pot was a contributing - but in no way a causal - factor in my first
crisis, however, and that smoking played a role in the several years onf
decline that led to that crisis. But tellingly this was all wildly
overstated by the hospital doctors who interviewed me. When I moved to
Conard House, an outpatient facility in San Francisco, I was sent to a
mandatory anti-drug meeting along with every marijuana user at the
house, regardless of the frequency of use or whether or not it was
abused or a problem.
When I challenge the meeting leader by saying that
marijuana was much safer than alcohol, I was kicked out of the program.
(I was sent to a homeless shelter at 14th and Mission, right next to a
thriving street crack market where I passed dealers every day on my way
to and from my room. A good friend of mine from a previous program, who
had been abstaining from cocaine for several years, was sent to the same
shelter, I watched as he gradually lost control of his addiction with
the temptation of those dealers; he left the shelter and I never heard
from him again.)
I think that CBD strains are promising, and I personally would not
hesitate to try a small dose of CBD marijuana in a time of emotional
distress where I felt I had run out of other options. I would watch
carefully my response, and proceed only if I felt confident I wasn’t
going to get paraoind or become anxious. Friends, clients, and
colleagues who use cannabis have educated me about its potential if I
did ever find myself in need, and have introduced me to the California
dispensary system.
I’m grateful I live in a state where I can learn
about these issues and can first try a CBD brownie (gluten free of
course) instead of a dose of Seroquel if I ever get out of hand with
sleep deprivation or go off the deep end in a psychosis. And when I’ve
seen friends go down to the psychotic vortex and head for the hospital, I
wish there was some CBD weed around to try first to help them break the
crisis cycle, rather than relying on a psych med as a last resort.
With clients I work with I now feel
it is unethical as a therapist to not include cannabis in the list of possible wellness tools for
those in legal states. I am pro-choice regarding psych drugs, and if I
acknowledge that anti-psychotics, even with the risks, might be a wise
choice for some people, I would be completely, well, crazy not to
acknowledge that cannabis might be a wise choice for some people as
well. I’ve always welcomed herbal medicine and traditional chinese and
other treatments into the range of possible wellness choices, because
they have such a demonstrated history of helping so many people.
Cannabis also has such a history, and I believe everyone working in the
field as a therapist or psychiatrist needs to consider taking the same
stance I have.
From a mental health advocacy standpoint, marijuana legalization also
has many other implications that we as mental health professionals
should look at. The AMA, APA, NAMI and other groups have failed to meet
this issue responsibly. An
American Journal of Public Health study
by a team of economists, for example, examined states that had
legalized marijuana for medical use.
The study found there was a 10.8
percent reduction in the suicide rate of men in their 20s and a 9.4
percent reduction in men in their 30s. That is extraordinary - we know
that psychiatric drug use can exacerbate suicidality (the drug warning
is right there on the label), and alcohol of course can contribute to
suicidality. It’s not clear exactly why greater availability of medical
cannabis might lower suicide rates, but this is a very, very significant
finding to study further for anyone who takes suicide prevention
seriously.
(I recently lost a dear friend to suicide, and I am convinced
benzodiazepines and alcohol played a role in killing her. I wish her
therapist and doctors had explored cannabis as an alternative - she
needed any alternative - and her death is one of the things motivating
me to write this blog post and “come out” with my clinical practice
decisions around cannabis.)
Studies also show reduction in alcohol use results from legalization,
which, again, has enormous implications. Alcohol is an extremely
dangerous and socially destructive drug with notorious mental health
harms.
The National Council on Alcoholism and Drug Dependence reports
that
alcohol use is a factor in 40 percent of all violent crimes in the United States,
including 37 percent of rapes and 27 percent of aggravated assaults. In
1995 alone, college students reported more than 460,000 alcohol-related
incidents of violence in the US. A 2011 prospective study found that
dating abuse was associated with drinking among college students.
A 2014
study found marijuana had clearly lower rates of associated domestic
and partner violence. As pro-legalization comedian Bill Hicks remarked,
imagine you are at a sporting event and some guy in front of you is
screaming and picking a fight: is he high on marijuana or is he drunk on
alcohol?
Reducing alcohol use in society will likely reduce violence; reducing
violence means reducing trauma in society as a whole.
When did we lose
sight of ending violence as a way of
preventing the cause of so
many mental health problems? And legalization has already reduced
traffic fatalities associated with drunk driving in states where it is
legal - each traffic death sends out shockwaves of trauma and grief, and
turns many people to alcohol or psychiatric drugs. (Hicks also said the
biggest traffic danger from driving high is hitting the garage door
because you forgot to open it.) Marijuana legalization is an upstream
solution with huge implications.
From a public health standpoint there
is really no argument: if we can bring alcohol use down in society, then
marijuana legalization is clearly worth it. According to the Centers
for Disease Control, abuse of prescription opioids such as Oxy-Contin
and Vicodin is a national epidemic that kill 16,000 people annually and
devastate lives and families. Cannabis legalization could also reduce
the market and illegal demand for opiods, easing this epidemic.
Legalization of cannabis also has important implications for young
people and families - once we understand the complexity of substance
use. The War on Drugs has devastated the US black community, and it is
shameful that white-dominated mental health organizations have not
spoken up against prohibition. Prison and the police are a traumatizing
factor that directly interfere with mental health recovery. While
legalization, according to the
Journal of Adolescent Health, has
not led to an increase in teen marijuana use, it does give families and
youth more flexibility.
For young people using cannabis, it might be
more realistic to switch the kind of cannabis they are using as a harm
reduction approach, rather than giving cannabis up completely. Many
young people are committed to cannabis as a lifestyle, a form of
religious expression, and a pathway to independence. Under prohibition
it is impossible to talk openly about their cannabis experiences, and
difficult to differentiate cannabis strains they are consuming.
It may
be easier for a teen to hear "use CBD strains, not the THC strains" than
for them to hear "you have to stop smoking entirely;” “You can smoke
pot, but in moderation" might work better than "you can't get high at
all."
A harm reduction perspective is best served by legalization.
Collaborative relationships require honesty: young people today know
that different strains do different things, and they know the hypocrisy
of a War On Drugs that sends people to jail for smoking a joint and then
sells their lawyer whiskey at the bar next to the courthouse.
Overgeneralized associations between marijuana and mental health
problems, including psychosis, ignore a complex reality.
Adolescents using marijuana who get into emotional and psychological
difficulties are like any adolescents who get into emotional and
psychological difficulties, for whatever reason. They need help and
support. The family needs help and support. The problem is never
“marijuana plus genetics equals psychotic disorder.” The marijuana may,
or may not, be part of the problem. When families — and doctors —are
blaming the marijuana it is usually a sign of a deeper problem being
avoided.
Prohibition is based on fear, the same fear behind the search
for a simplistic answer, something to grab ahold of as the solution in a
situation that feels out of control.
Cannabis use then often becomes a power struggle in families. As a
therapist I have seen time and time again families where a son or
daughter has been psychotic after using marijuana, and the family's
response is to ban their son or daughter from using. So what does the
young person do? They keep smoking, of course, except now they have a
new problem: hiding from the parents, a power struggle with their
parents, and the beginning of a cycle of isolation if the power struggle
continues.
I have to work hard to stay in a trusting relationship with
both sides, and that job gets harder the more prohibition fear
entrenches intolerance. The solution is to create conversations about
the substance; even if the parents are strongly against any marijuana
use, it’s important to respect all sides, but on an equal playing fiend
where the young person can be validated for a choice that has some
science on its side. Dismissing one side doesn’t help. Doesn’t it make
more sense to say Let's talk? than to Just Say No?
I have no doubt that marijuana use has played a role in many people’s
problems with psychosis. I routinely work with people to encourage them
to stop smoking when they know it can lead to crisis. I’ve seen people
off marijuana start using again and end up hospitalized. And marijuana
can certainly lead to habituation for some people and play a role in
substance problems. Educating society about these risks makes the same
sense that educating society about alcohol risks makes sense - as long
as the risks are not exaggerated.
Personally I would like to see
cannabis avoid the commercialization of alcohol and be a more accepted -
but not promoted or advertised - personal option. We really don’t need
any more consumerism than we already have. Instead, we need an honesty
and smart use that we really don’t even have with alcohol, with all the
alcohol advertising and the culture of happy hour and spring break.
And of the risks, what about the correlation between first break
psychosis with a higher rate of marijuana use? There is in my view
validity to that concern — and it also be at least in part misleading.
What if the causality is sometimes in the other direction? What if
people who end up psychotic are drawn to altered states of consciousness
in general, what if they first seek out in marijuana what they
eventually end up later seeking in their break to a psychotic reality?
Working with young people over many years, I see the need to get "high"
comes first, not after, the substance. Few families have honest
discussions about the need to get high and get away - how it is a human
need that everyone has.
And getting high repeatedly may be an escape
hatch out of untenable life circumstances and confusing options. Maybe a
young person is drawn to cannabis by the same inner need that will
eventually draw them to psychosis, correlating the two - but not
indicating causality.
As we come to terms with the devastating impact that psychiatric
drugs have on society, we face a compelling question: What if there was a
substitute? Someone considering a benzo, or an anti-psychotic, or an
anti-depressant, is about to embark on a risky treatment option that
might work out fine, or might end up destroying their life.
That is the
reality of the risks of psychiatric drugs. The Soteria House alternative
and the Open Dialogue approach, it should be remembered, do rely on
psychiatric drugs as a last resort. What if everyone had, on a wide
scale, the option of choosing something with a lower side effect
profile, and perhaps thereby could be diverted from a risky pathway?
That may be what the US is on the brink of with legalization. And what
exactly do we know of Pharma’s influence in opposing marijuana
legalization?
The American Medical Association and APA have long opposed
legalization; does medical cannabis represent a threat to Pharma
markets?
These social implications have not gone unnoticed by the web of
financial interests benefitting from cannabis prohibition. The same
public policy corruption driving psychiatric drug use is also evident in
efforts to block legalization. Dr. Herbert Kleber of Columbia
University, an impeccably credentialed academic, is widely quoted in the
press warning against marijuana - and also serves as a paid consultant
to leading prescription drug companies.
Oxy-Contin manufacturer Purdue
Pharma and Vicodin manufacturer Abbott Laboratories are among the
leading funders of the Community Anti-Drug Coalition of America and
Partnership for Drug Free Kids - both fierce prohibition advocates.
(Other funders include Janssen and Pfizer.) When Patrick Kennedy’s
so-called Project SAM (Smart Approaches to Marijuana) worked against
Alaska’s legalization initiative, activists counterattacked by pointing
out the organizations extensive financial ties to the liquor and beer
lobby.
Dr. Stuart Gitlow, President of the American Society Of Addiction
Medicine, another legalization opponent, went on the media circuit
disputing President Obama’s statement that marijuana is no more
dangerous than alcohol: Gitlow serves as medical director for pharma
company Orexo, an opioid manufacturer. Former Drug Enforcement
Administration head Peter Bensinger and former White House drug czar
Robert DuPont (yes that was his title) now run a commercial firm that
specializes in the market for workplace drug testing.
While some police have come out against the War on Drugs, many police
are lobbying in favor of it. Is it because they receive millions in
funds to use under drug money seizure and assets forfeiture laws? One
Florida sheriff who led opposition to legalization went so far as to
state openly that drug asset forfeitures were important for county law
enforcement resources. California legalization was opposed by another
police lobbyist who made a career of funneling federal War on Drugs
grants to state law enforcement.
This is corruption in the crudest form :
a mandate for serving public good diverted to individual gain.
As Los Angeles Police Department Deputy Chief Stephen Downing told
The Nation,
“The only difference now compared to the times of alcohol prohibition
is that, in the times of alcohol prohibition, law enforcement—the police
and judges—got their money in brown paper bags. Today, they get their
money through legitimate, systematic programs run by the federal
government.
That’s why they’re using their lobbying organizations to
fight every reform.” Legalization means challenging economies of
influence and politics of corruption that have made drug policy and
criminalization big business. Importantly, ending alcohol Prohibition in
1933 involved a vast clearing out of this corruption from the federal
to the local level; hopefully the grassroots drive for cannabis policy
reform will likewise have wide anti-corruption implications.
Even when we support cautious consideration and avoid making any
blanket endorsement, cannabis is a powerful psychoactive plant that
involves risks. Small controlled doses - a few drops of tincture, a
small puff from a cigarette, a single edible candy - are still
unpredictable, and might launch someone onto an unpleasant altered
state, make working or relating in public difficult, trigger insomnia,
interfere with driving, set someone down a path to addiction, or worse.
Harms to memory and cognition development among adolescents might reveal
themselves after long term heavy use. There are risks: it’s not a one
size fits all solution. It will take some time to sort out studies and
research honestly and get a realistic sense of the social impact in the
wake of a politicized and corrupted research legacy.
And this underscores one of the central problems with the cannabis
policy discussion. Legalization activists wisely chose to emphasize
medical uses on a pathway towards greater marijuana acceptance.
But in
practice, as a plant medicine, cannabis has never been and probably
never will be a targeted medical treatment. It is a plant, not a pill.
Cannabis is a choice to introduce a substance into one’s body that will
have unique and unpredictable effects on consciousness. It’s a life
decision. It changes you, in subtle ways or dramatic ways, to ingest a
substance.
Like regularly taking alcohol, drinking coffee daily, smoking
cigarettes, and the use of food and herbal medicines in traditional
cultures, marijuana is really best understood as a relationship.
The
human body and mind have receptors uniquely designed to interact with
cannabis, which helps explain the broad range of consciousness and
physical health effects now bing studied and experienced. Specific uses
and strains might target symptoms associated with a diagnosis, but
cannabis is not like penicillin. Only the individual knows how
perception and consciousness are altered, and whether that is
experienced as a plus or a minus in life.
Some people will choose to be
high if it goes along with reduction of some other discomfort; others
will prefer to avoid getting high in any form. From food to movies to
wine to sexuality, “self-medicating” is after all a widespread social
practice and should be acknowledged: we all, to some degree, medicate
ourselves just as we all, to some degree, get high. And this is what we
have overlooked in our understanding of psychiatric drugs - they too are
very powerful mind altering substances that get us “high.”
It’s not
what we think of as a high, we are still altered when we take our
Zyprexa or our Prozac, and some psychiatric drugs, such as the
benzodiazepines and the stimulants, are widely used recreationally. The
psychiatric drugs have clear toxicities to the body; cannabis has
extremely few, and a wide profile of benefits. That’s why it’s been used
around the world as medicine since prehistoric times. It is also mind
altering, despite the emphasis on “medical” use, and we need to
recognize that altering our minds is part of what we do as humans.
We need the freedom, especially when we are facing extreme distress
and crisis, to choose what risks we want to take and what substances we
want to introduce, or not introduce, into our bodies and minds. We are
bombarded by physical and psychological stresses in virtually every
aspect of our lives today. Some of us choose alcohol, Some of us choose
yoga, running, and organic food. Some us will choose cannabis. We need
to take a principled and ethical look at that choice, and we need to
ensure that people exploring this option aren’t put in jail for it.